Post by Viatris on X
Viatris@ViatrisInc
XToday we announced that the US FDA has accepted our sNDA for an investigational treatment for presbyopia, an age-related progressive loss of the ability to focus on close objects that results in blurred near vision and eye strain. More information: t.co
12 likes0 repliesPosted Feb 25, 2026